| Literature DB >> 25873518 |
Weiguo Chen1, Yang Liu1, Hongxing Li1, Shuang Chang2, Dingming Shu3, Huanmin Zhang4, Feng Chen5, Qingmei Xie6.
Abstract
The group of avian sarcoma and leukosis virus (ASLV) in chickens contains six highly related subgroups, A to E and J. Four genetic loci, tva, tvb, tvc and tvj, encode for corresponding receptors that determine the susceptibility to the ASLV subgroups. The prevalence of ASLV in hosts may have imposed strong selection pressure toward resistance to ASLV infection, and the resistant alleles in all four receptor genes have been identified. In this study, two new alleles of the tva receptor gene, tva(r5) and tva(r6), with similar intronic deletions were identified in Chinese commercial broilers. These natural mutations delete the deduced branch point signal within the first intron, disrupting mRNA splicing of the tva receptor gene and leading to the retention of intron 1 and introduction of premature TGA stop codons in both the longer and shorter tva isoforms. As a result, decreased susceptibility to subgroup A ASLV in vitro and in vivo was observed in the subsequent analysis. In addition, we identified two groups of heterozygous allele pairs which exhibited quantitative differences in host susceptibility to ASLV-A. This study demonstrated that defective splicing of the tva receptor gene can confer genetic resistance to ASLV subgroup A in the host.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25873518 PMCID: PMC4397534 DOI: 10.1038/srep09900
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Alleles tvar5 and tvar6 in Chinese commercial broiler lines containing deletions in intron 1 of tva receptor gene.
Partial genomic sequence showing intron 1 and junctions with exons 1 and 2 in the tva gene. The regions of the branch point with corresponding deletions in the tvar5 and tvar6 alleles are indicated below, and the deleted bases are represented by dashes. The deduced branch point signal is boxed, and the GT-AG intron termini are shown in bold. The underlined sequences indicate the putative alternative branch point signals. The intron-exon junctions are indicated by vertical bars, while exon sequences are indicated in italics. The nucleotide numbering based on the published tvas allele genomic sequence (GenBank accession number: AY531262.1) is provided for reference.
Genotypic frequency of tvamut502–516 multiple allele1 in Chinese commercial broiler lines
| Line | No. | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 202 | 44 | 0 | 0 | 0.12 | 0 | 0 | 0.07 | 0.52 | 0 | 0 | 0.02 | 0.11 | 0 | 0.11 | 0 | 0.05 |
| 203 | 29 | 0.31 | 0 | 0 | 0 | 0 | 0.10 | 0.41 | 0 | 0 | 0 | 0.14 | 0 | 0.03 | 0 | 0 |
| 204 | 30 | 0.23 | 0 | 0 | 0 | 0 | 0.17 | 0.27 | 0.03 | 0 | 0.13 | 0.10 | 0 | 0.07 | 0 | 0 |
| 205 | 30 | 0.57 | 0 | 0 | 0 | 0 | 0.17 | 0 | 0.13 | 0 | 0 | 0 | 0 | 0.10 | 0 | 0.03 |
| 207 | 29 | 0 | 0 | 0 | 0 | 0.08 | 0.03 | 0 | 0.26 | 0.10 | 0 | 0.03 | 0 | 0 | 0 | 0.41 |
| 208 | 27 | 0.22 | 0 | 0 | 0 | 0 | 0.19 | 0.11 | 0.37 | 0 | 0.04 | 0.04 | 0 | 0.04 | 0 | 0 |
| 209 | 28 | 0.18 | 0 | 0 | 0 | 0 | 0.21 | 0.00 | 0.43 | 0 | 0.07 | 0.04 | 0 | 0.04 | 0 | 0.04 |
| 301 | 41 | 0.20 | 0 | 0 | 0 | 0 | 0.20 | 0.02 | 0.34 | 0 | 0.02 | 0.17 | 0 | 0.02 | 0 | 0.02 |
| 306 | 31 | 0 | 0 | 0 | 0.13 | 0 | 0.16 | 0 | 0.55 | 0 | 0 | 0.10 | 0.03 | 0 | 0 | 0.03 |
| 406 | 26 | 0.27 | 0.04 | 0 | 0 | 0 | 0.31 | 0.08 | 0 | 0 | 0.12 | 0.08 | 0 | 0.08 | 0.04 | 0 |
| 407 | 40 | 0.10 | 0.05 | 0.05 | 0 | 0 | 0 | 0.05 | 0.35 | 0 | 0.05 | 0.05 | 0 | 0.30 | 0 | 0 |
| 408 | 30 | 0.07 | 0 | 0 | 0.07 | 0 | 0.10 | 0.27 | 0 | 0 | 0.27 | 0.17 | 0 | 0.07 | 0 | 0 |
| 411 | 27 | 0.04 | 0 | 0 | 0 | 0 | 0.15 | 0.30 | 0.11 | 0.04 | 0.22 | 0.07 | 0.04 | 0 | 0.04 | 0 |
| 413 | 29 | 0.38 | 0.03 | 0.03 | 0 | 0 | 0.28 | 0 | 0 | 0 | 0.21 | 0.03 | 0 | 0.03 | 0 | 0 |
| 417 | 42 | 0.14 | 0 | 0 | 0 | 0 | 0.14 | 0.29 | 0.05 | 0 | 0.19 | 0.05 | 0 | 0.14 | 0 | 0 |
| 418 | 28 | 0.14 | 0.04 | 0 | 0 | 0 | 0.25 | 0.07 | 0.04 | 0 | 0.18 | 0.25 | 0 | 0.04 | 0 | 0 |
| 419 | 46 | 0.13 | 0 | 0 | 0 | 0 | 0.04 | 0.33 | 0.04 | 0.02 | 0.04 | 0.17 | 0 | 0.04 | 0.04 | 0.13 |
| 501 | 29 | 0.17 | 0 | 0 | 0 | 0 | 0.17 | 0.07 | 0 | 0 | 0.34 | 0.17 | 0 | 0.07 | 0 | 0 |
| 502 | 28 | 0.21 | 0 | 0 | 0.04 | 0.04 | 0.21 | 0.11 | 0 | 0 | 0.04 | 0.21 | 0 | 0.04 | 0.11 | 0 |
| 505 | 30 | 0.13 | 0 | 0 | 0 | 0 | 0.07 | 0.07 | 0.47 | 0 | 0 | 0.07 | 0 | 0.20 | 0 | 0 |
| 511 | 38 | 0.32 | 0 | 0 | 0 | 0 | 0.11 | 0.11 | 0.16 | 0 | 0 | 0.05 | 0 | 0.16 | 0 | 0.11 |
| 603 | 30 | 0.20 | 0.03 | 0.03 | 0.07 | 0 | 0.13 | 0.20 | 0.03 | 0 | 0.07 | 0.10 | 0.07 | 0.03 | 0 | 0.03 |
1tvamut502–516 = multiple allele of tvar3, tvar4, tvar5 and tvar6 at the tva locus.
2tvas/s = susceptible homozygote of tva receptor gene; tvas/r3 = heterozygote of deleted ACCCCGCCCC; tvas/r4 = heterozygote of deleted ACCCC; tvas/r5 = heterozygote of deleted CGCTCACCCC; tvas/r6 = heterozygote of deleted CGCTCACCCCGCCCC; tvar3/r3 = homozygote of deleted ACCCCGCCCC; tvar4/r4 = homozygote of deleted ACCCC; tvar5/r5 = homozygote of deleted CGCTCACCCC; tvar6/r6 = homozygote of deleted CGCTCACCCCGCCCC; tvar3/r4 = heterozygote of deleted ACCCCGCCCC and ACCCC; tvar3/r5 = heterozygote of deleted ACCCCGCCCC and CGCTCACCCC; tvar3/r6 = heterozygote of deleted ACCCCGCCCC and CGCTCACCCCGCCCC; tvar4/r5 = heterozygote of deleted ACCCC and CGCTCACCCC; tvar4/r6 = heterozygote of deleted ACCCC and CGCTCACCCCGCCCC; and tvar5/r6 = heterozygote of deleted CGCTCACCCC and CGCTCACCCCGCCCC.
Figure 2Deletion of internal intron 1 sequences affects splicing of tva receptor gene.
(A) Schematic diagram of intron 1 in tva pre-mRNA showing the 5′ splice site, 3′ splice site and the branch point sequence (corresponding bases are indicated by dots). The adenosine residue which is required for the first cleavage-ligation step of the splicing reaction18 is marked by an arrow. (B) Schematic diagram of RT-PCR strategy. The use of PCR primers TVA3 and TVA4 generated easily discernible whole cDNA fragments that were amplified from the longer and shorter tva forms, respectively, as well as the longer and shorter tva forms with intron 1 retention. Sizes of diagnostic PCR products are indicated. Exons are drawn as boxes, retained introns are shown as black lines and spliced introns as diagonal lines. The vertical white bar indicates the position of the intronic deletion. (C) RT-PCR of RNA isolated from DF-I cells and samples from lives of defined origin. Lane 1–16 indicated the RT-PCR products from DF-I cells and the tvas/s, tvas/r3, tvas/r4, tvas/r5, tvas/r6, tvar3/r3, tvar4/r4, tvar5/r5, tvar6/r6, tvar3/r4, tvar3/r5, tvar3/r6, tvar4/r5, tvar4/r6 and tvar5/r6 samples from lives, respectively. Positions of full-length and intron 1 retention PCR products are indicated on the right, and sizes of diagnostic PCR products are indicated on the left. Spliced products from the full-length longer and shorter tva forms (Full-length-L and Full-length-S) migrated slightly faster than the corresponding RNAs of the mutants (Full-length-L-Int1 and Full-length-S-Int1). The gels have been run under the same experimental conditions, and the cropped gels are used. The full-length gel images are presented in the supplementary information. (D) Separate sequence analysis of PCR products revealed normal splicing of longer and shorter tva forms of tvas/s homozygotes, while splicing of longer and shorter tva forms of tvar5/r5 and tvar6/r6 homozygotes containing intron 1 with the corresponding deletion mutation, however, the tvas/r3, tvas/r4, tvas/r5 and tvas/r6 heterozygotes generate both the normal splicing of shorter tva forms and abnormal splicing of longer and shorter tva forms. Stars represent premature TGA stop codons identified in the alternative transcript.
Figure 3Construction of RCASBP(A)-EGFP.
(A) Schematic representation of strategy for construction of RCASBP(A)-EGFP. Restriction sites used for construction of RCASBP(A)-EGFP are indicated. EGFP, with the size, is indicated. (B) Restriction enzyme digestion analysis of pVAX1-EGFP, Cla12Nco-EGFP and RCASBP(A)-EGFP vectors. (C) Fluorescence microscopy of transduced DF-I cells confirming EGFP marker gene expression.
Figure 4Time course of ASLV-A infection of DF-I cells and CEFs of defined origin.
DF-I cells (tvas/s) and CEFs of defined origin were inoculated at a the multiplicity of infection of 10 with replication-competent ASLV encoding the EGFP reporter protein, RCASBP(A)-EGFP. (A) Proportions of GFP-positive cells were determined by FACS on indicated days post-infection. Results are means of data from three parallel dishes. (B) Representative FACS histograms of CEFs infected with RCASBP(A)-GFP at 7 days post-infection. The relative GFP fluorescence is plotted against the cell count, and the percentage of GFP-positive cells is indicated.
Incidence of RT-PCR positivity for avian leukosis virus subgroup A at one month post-infection in chicks with different genotypes of the tvamut502–516 multiple allele1
| 45/45 | 9/9 | 5/5 | 8/9 | 5/5 | 4/32 | 1/18 | 0/15 | 1/11 | 0/6 | 0/9 | 0/5 | 0/8 | 0/6 | 1/17 |
1tvamut502–516 = multiple allele of tvar3, tvar4, tvar5 and tvar6 at the tva locus.
2tvas/s = susceptible homozygote of tva receptor gene; tvas/r3 = heterozygote of deleted ACCCCGCCCC; tvas/r4 = heterozygote of deleted ACCCC; tvas/r5 = heterozygote of deleted CGCTCACCCC; tvas/r6 = heterozygote of deleted CGCTCACCCCGCCCC; tvar3/r3 = homozygote of deleted ACCCCGCCCC; tvar4/r4 = homozygote of deleted ACCCC; tvar5/r5 = homozygote of deleted CGCTCACCCC; tvar6/r6 = homozygote of deleted CGCTCACCCCGCCCC; tvar3/r4 = heterozygote of deleted ACCCCGCCCC and ACCCC; tvar3/r5 = heterozygote of deleted ACCCCGCCCC and CGCTCACCCC; tvar3/r6 = heterozygote of deleted ACCCCGCCCC and CGCTCACCCCGCCCC; tvar4/r5 = heterozygote of deleted ACCCC and CGCTCACCCC; tvar4/r6 = heterozygote of deleted ACCCC and CGCTCACCCCGCCCC; and tvar5/r6 = heterozygote of deleted CGCTCACCCC and CGCTCACCCCGCCCC.